Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shuanghua Baihe Tablet for prevention and treatment of chemoradiotherapy-induced oral mucositis in nasopharyngeal carcinoma
ChiCTR-TRC-14004197Phase 4Completed
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Aug 2013
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Shuanghua Baihe in stomatitis (2 arms), sponsored by Peking University Cancer Hospital & Institute. Primary endpoint: Incidence and time to onset of oral mucositis. Started Aug 2013; status: completed.
02
Drugs
Shuanghua Baihe
03
Conditions
stomatitis
Beyond the preview
Go deeper on ChiCTR-TRC-14004197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004197.